Chai Bio is a leading player in AI protein design and has already translated its models into a significant commercial deal with Eli Lilly, validating the near-term revenue potenti…

Arc Institute's Evo 2 model, trained on a trillion DNA bases, represents a major advance in genomic foundation models that can serve as a tool for reasoning models to design biolo…

Madra is attempting to automate the 'back end' of lab work using robotic arms, but the approach faces the same high-mix, low-volume integration challenges that have historically l…

OpenAI's reasoning models can successfully design and iterate experimental workflows in a robotic lab, achieving a 40% improvement over the state-of-the-art in cell-free protein s…

Ginkgo is focusing on the 'back end' of biology — making physical experimentation cheaper and faster via autonomous robotic labs — and now sells both the hardware (reconfigurable…

Isomorphic Labs, with Alphabet/DeepMind's deep pockets and vertical integration, is the most credible candidate to validate AI-driven drug discovery through clinical candidates, o…

The AlphaChip team from Google, now backed by Sequoia, demonstrates that AI can already achieve superhuman chip design — a 'Move 37' moment for semiconductors that signals pocket…